Literature DB >> 29058307

Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.

A Schlüter1,2, M Horstmann1, S Diaz-Cano3, S Plöhn1, K Stähr2, S Mattheis2, M Oeverhaus4, S Lang2, U Flögel5, U Berchner-Pfannschmidt1, A Eckstein1,4, J P Banga1.   

Abstract

Experimental models of Graves' hyperthyroid disease accompanied by Graves' orbitopathy (GO) can be induced efficiently in susceptible inbred strains of mice by immunization by electroporation of heterologous human TSH receptor (TSHR) A-subunit plasmid. In this study, we report on the development of a bona fide murine model of autoimmune Graves' disease induced with homologous mouse TSHR A-subunit plasmid. Autoimmune thyroid disease in the self-antigen model was accompanied by GO and characterized by histopathology of hyperplastic glands with large thyroid follicular cells. Examination of orbital tissues showed significant inflammation in extra-ocular muscle with accumulation of T cells and macrophages together with substantial deposition of adipose tissue. Notably, increased levels of brown adipose tissue were present in the orbital tissue of animals undergoing experimental GO. Further analysis of inflammatory loci by 19 F-magnetic resonance imaging showed inflammation to be confined to orbital muscle and optic nerve, but orbital fat showed no difference in inflammatory signs in comparison to control β-Gal-immunized animals. Pathogenic antibodies induced to mouse TSHR were specific for the self-antigen, with minimal cross-reactivity to human TSHR. Moreover, compared to other self-antigen models of murine Graves' disease induced in TSHR knock-out mice, the repertoire of autoantibodies to mouse TSHR generated following the breakdown of thymic self-tolerance is different to those that arise when tolerance is not breached immunologically, as in the knock-out models. Overall, we show that mouse TSHR A-subunit plasmid immunization by electroporation overcomes tolerance to self-antigen to provide a faithful model of Graves' disease and GO.
© 2017 British Society for Immunology.

Entities:  

Keywords:  Graves' disease; Graves' orbitopathy; autoimmunity; self-antigen mouse model; thyroid disease

Mesh:

Substances:

Year:  2017        PMID: 29058307      PMCID: PMC5801504          DOI: 10.1111/cei.13075

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

Review 1.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

2.  Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.

Authors:  Alexander V Misharin; Yuji Nagayama; Holly A Aliesky; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2009-03-05       Impact factor: 4.736

Review 3.  Searching for ways to switch on brown fat: are we getting warmer?

Authors:  Andrew Whittle
Journal:  J Mol Endocrinol       Date:  2012-08-30       Impact factor: 5.098

4.  Requirement for Transcription Factor Ets1 in B Cell Tolerance to Self-Antigens.

Authors:  Lisa Russell; Shinu John; Jaime Cullen; Wei Luo; Mark J Shlomchik; Lee Ann Garrett-Sinha
Journal:  J Immunol       Date:  2015-09-09       Impact factor: 5.422

5.  Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.

Authors:  Gina-Eva Görtz; Sajad Moshkelgosha; Christoph Jesenek; Bärbel Edelmann; Mareike Horstmann; J Paul Banga; Anja Eckstein; Utta Berchner-Pfannschmidt
Journal:  Endocrinology       Date:  2016-08-23       Impact factor: 4.736

6.  Induction of experimental autoimmune Graves' disease in BALB/c mice.

Authors:  S Kaithamana; J Fan; Y Osuga; S G Liang; B S Prabhakar
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

7.  Enhanced response to mouse thyroid-stimulating hormone (TSH) receptor immunization in TSH receptor-knockout mice.

Authors:  Mami Nakahara; Norisato Mitsutake; Hikaru Sakamoto; Chun-Rong Chen; Basil Rapoport; Sandra M McLachlan; Yuji Nagayama
Journal:  Endocrinology       Date:  2010-06-16       Impact factor: 4.736

8.  Graves' disease TSHR-stimulating antibodies (TSAbs) induce the activation of immature thymocytes: a clue to the riddle of TSAbs generation?

Authors:  Mireia Giménez-Barcons; Roger Colobran; Ana Gómez-Pau; Ana Marín-Sánchez; Anna Casteràs; Gabriel Obiols; Raúl Abella; Joaquín Fernández-Doblas; Massimo Tonacchera; Ana Lucas-Martín; Ricardo Pujol-Borrell
Journal:  J Immunol       Date:  2015-03-23       Impact factor: 5.422

Review 9.  Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics.

Authors:  Yaron Tomer
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

10.  The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.

Authors:  Chun-Rong Chen; Pavel Pichurin; Yuji Nagayama; Francesco Latrofa; Basil Rapoport; Sandra M McLachlan
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more
  12 in total

1.  A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.

Authors:  Sandra M McLachlan; Holly A Aliesky; Basil Rapoport
Journal:  Thyroid       Date:  2019-07-03       Impact factor: 6.568

Review 2.  A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocrine       Date:  2019-09-27       Impact factor: 3.633

3.  The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy.

Authors:  Catherine J Choi; Wensi Tao; Ravi Doddapaneni; Zenith Acosta-Torres; Nathan W Blessing; Bradford W Lee; Daniel Pelaez; Sara T Wester
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799

4.  Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.

Authors:  Christine L Hammond; Elisa Roztocil; Richard P Phipps; Steven E Feldon; Collynn F Woeller
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

5.  Temperature and species-dependent regulation of browning in retrobulbar fat.

Authors:  Fatemeh Rajaii; Dong Won Kim; Jianbo Pan; Nicholas R Mahoney; Charles G Eberhart; Jiang Qian; Seth Blackshaw
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

Review 6.  Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.

Authors:  Sijie Fang; Yi Lu; Yazhuo Huang; Huifang Zhou; Xianqun Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

7.  Distinctive Features of Orbital Adipose Tissue (OAT) in Graves' Orbitopathy.

Authors:  Lei Zhang; Anna Evans; Chris von Ruhland; Mohd Shazli Draman; Sarah Edkins; Amy E Vincent; Rolando Berlinguer-Palmini; D Aled Rees; Anjana S Haridas; Dan Morris; Andrew R Tee; Marian Ludgate; Doug M Turnbull; Fredrik Karpe; Colin M Dayan
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

8.  Noninflammatory Diffuse Follicular Hypertrophy/Hyperplasia of Graves Disease: Morphometric Evaluation in an Experimental Mouse Model.

Authors:  Anke Schlüter; Anja K Eckstein; Alexandra Brenzel; Mareike Horstmann; Stephan Lang; Utta Berchner-Pfannschmidt; J Paul Banga; Salvador Diaz-Cano
Journal:  Eur Thyroid J       Date:  2018-04-13

9.  Graves' orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model.

Authors:  Anke Schlüter; Ulrich Flögel; Salvador Diaz-Cano; Gina-Eva Görtz; Kerstin Stähr; Michael Oeverhaus; Svenja Plöhn; Stefan Mattheis; Lars C Moeller; Stephan Lang; Nikolaos E Bechrakis; J Paul Banga; Anja Eckstein; Utta Berchner-Pfannschmidt
Journal:  Sci Rep       Date:  2018-08-30       Impact factor: 4.379

10.  Viral gene delivery vectors: the next generation medicines for immune-related diseases.

Authors:  Peter De Haan; Ferdy R Van Diemen; Miguel G Toscano
Journal:  Hum Vaccin Immunother       Date:  2020-05-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.